Similar Papers

Paper Title
Journal
Date
Author
Improved Outcomes Using Tacrolimus/Sirolimus for Graft-versus-Host Disease Prophylaxis with a Reduced-Intensity Conditioning Regimen for Allogeneic Hematopoietic Cell Transplant as treatment of Myelofibrosis
David S Snyder ... Stephen J Forman
Biology of Blood and Marrow Transplantation | VOL. 16
David S Snyder, et. al.David S Snyder ... Stephen J Forman
26 Sep 2009
Predictive factors for outcomes after reduced intensity conditioning hematopoietic stem cell transplantation for hematological malignancies: a 10-year retrospective analysis from the Société Française de Greffe de Moelle et de Thérapie Cellulaire
Mauricette Michallet ... Didier Blaise
Experimental Hematology | VOL. 36
Mauricette Michallet, et. al.Mauricette Michallet ... Didier Blaise
17 Mar 2008
Low-Dose Total Body Irradiation and Fludarabine Conditioning for HLA Class I-Mismatched Donor Stem Cell Transplantation and Immunologic Recovery in Patients with Hematologic Malignancies: A Multicenter Trial
Hirohisa Nakamae ... Brenda M Sandmaier
Biology of Blood and Marrow Transplantation | VOL. 16
Hirohisa Nakamae, et. al.Hirohisa Nakamae ... Brenda M Sandmaier
10 Nov 2009
HLA-C Antigen Mismatch Is Associated with Worse Outcome in Unrelated Donor Peripheral Blood Stem Cell Transplantation
Ann Woolfrey ... Stephanie J Lee
Biology of Blood and Marrow Transplantation | VOL. 17
Ann Woolfrey, et. al.Ann Woolfrey ... Stephanie J Lee
24 Sep 2010
View more papers

More From: Transplantation and Cellular Therapy

Paper Title
Journal
Date
Author
Pediatric Transplant and Cellular Therapy Consortium RESILIENT Conference on Pediatric Chronic Graft-versus-Host Disease Survivorship after Hematopoietic Cell Transplantation: Part II. Organ Dysfunction and Immune Reconstitution Considerations for children with chronic GVHD after Hematopoietic Cell Transplantation.
Saldaña Bj Dávila ... K M Williams
Transplantation and cellular therapy | VOL. -
Saldaña Bj Dávila, et. al.Saldaña Bj Dávila ... K M Williams
22 Jan 2025
Prolonged neurologic symptoms following immune effector cell-associated neurotoxicity syndrome in patients with large B cell lymphoma treated with chimeric antigen receptor-modified T cell therapy.
Luke Maillie ... Daniel J Landsburg
Transplantation and cellular therapy | VOL. -
Luke Maillie, et. al.Luke Maillie ... Daniel J Landsburg
21 Jan 2025
Low Survival Due to Higher Risk of Relapse and Nonrelapse Mortality After Allogeneic HSCT in ATL Compared with AML and ALL.
Shohei Tomori ... Makoto Yoshimitsu
Transplantation and cellular therapy | VOL. -
Shohei Tomori, et. al.Shohei Tomori ... Makoto Yoshimitsu
17 Jan 2025
Refining Risk Stratification for B-cell Precursor Adult Acute Lymphoblastic Leukemia Treated With a Pediatric-inspired Regimen by Combining IKZF1 Deletion and Minimal Residual Disease.
Shiyu Deng ... Hongsheng Zhou
Transplantation and cellular therapy | VOL. -
Shiyu Deng, et. al.Shiyu Deng ... Hongsheng Zhou
09 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.